Industry: Blood Products - Digital Construction of the Whole Factory
Beijing Tiantan Biological Products is the earliest enterprise in China to engage in the industrial production of blood products. It owns several blood product companies such as Chengdu Ronsen, Lanzhou Biopharmaceutical, Shanghai Blood Products, Wuhan Biopharmaceutical, Guizhou Biopharmaceutical, Kunming Blood Products, and Xi'an Biopharmaceutical. It is the pioneer of China's blood product industry and the largest blood product enterprise in the country. As a long-term strategic partner, Wellthinic Technology actively helps Beijing Tiantan Biological Products build a digital factory, realizing the process-based, digital, and intelligent management of the entire production and operation process, improving production efficiency, and achieving a leap-forward increase in overall production capacity, making greater contributions to human health.
Solution Description:
Taking Opcenter as the digital foundation, relying on its leading Industry 4.0 technology, mature control concepts, and PCS7 software platform, it meets the requirements of GMP and blood product related regulations, provides compliant EBR design and SOP operation guidance, and ensures the standardization and traceability of the production process. Through the integration with various digital systems, it breaks down data silos, realizes efficient interconnection between the production control layer and the management layer, and constructs an end-to-end digital management system. The solution fully supports the full-process digital management and constructs a product quality traceability system, providing a flexible, stable, and compliant solid support for the construction of a digital factory.
Implementation Effect:
Achieve full-process digital management of the whole-factory automation and other aspects
Transform from the traditional production mode to the whole-factory automation control, with a 30% increase in production efficiency
Realize transparent real - time management of the production process and complete electronic batch records
Meet the requirements of GMP and blood product related regulations
Effectively improve the extraction rate
Establish a quality traceability system for the whole-process of product production, and the product production can meet the standard requirements of "golden batches"
Cooperative Projects and History:
2012, Chengdu Ronsen (Gaoxin) Blood Product Digital Factory Project
